Brought to you by:
Mechanical thrombectomy system for AV access shows promise, study shows
A retrospective analysis of 64 patients treated between 2022 and 2025 using a novel mechanical thrombectomy system to treat dialysis access thrombus showed function was restored in 91% of those treated. Data from the study of the InThrill system (Stryker/…
ATEV shows promise in high-risk patients on hemodialysis
Results from the CLN-PRO-V007 pivotal phase 3 clinical trial of the acellular tissue engineered vessel (ATEV; Humacyte) in arteriovenous access for patients at high risk of autologous arteriovenous fistula (AVF) maturation failure with end-stage renal disease were presented at the…
Early feasibility study for Velocity pAVF system now fully enrolled
Venova Medical has announced the completion of patient enrollment in the company’s VENOS-2 early feasibility study of the Velocity percutaneous arteriovenous fistula (pAVF) system for hemodialysis access. The multicenter study is being performed under an Investigational Device Exemption (IDE) granted…
Wrapsody WAVE trial demonstrates superior patency versus standard of care in AV fistula patients
Merit Medical has today announced positive six-month findings from the randomized arteriovenous (AV) fistula arm of its Wrapsody arteriovenous access efficacy (WAVE) pivotal trial. The data were shown at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual congress…
Vascular Therapies completes enrollment in the ACCESS 2 study
Vascular Therapies has today announced completion of enrollment in the ACCESS 2 trial, a Phase III prospective randomized, multicenter clinical study of Sirogen for the surgical creation of arteriovenous (AV) fistula in patients requiring hemodialysis vascular access. Vascular Therapies developed…
Improved fistulas and cost-effectiveness promised in plenary 5 abstract presentation
Friday morning’s Plenary Session 5 (8:00–9:30 a.m.) is set to feature new data on an external support device that may deliver more functional arteriovenous fistulas (AVFs) while also offering an improvement in cost-effectiveness. Presenting an abstract on research into the…
The top 10 most popular Vascular Specialist stories of February 2023
In February 2023, the hits with Vascular Specialist readers included positive safety and efficacy findings from the PRESERVE trial; the announcement of the scientific program for Sudan’s first vascular meeting; the release of a former Society for Vascular Surgery (SVS) President’s…